Lawyers for US cancer sufferers challenge Bayer's $7.25bn Roundup settlement deal [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
The weedkiller Roundup for sale in Encinitas, California, on 26 June 2017. Photograph: Mike Blake/Reuters · Photograph: Mike Blake/Reuters A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer 's proposed class action settlement of Roundup litigation, citing concerns that the deal will not be fair to cancer sufferers. The group filed both a motion to intervene and a motion for an extension of time for court preliminary approval of the deal in St Louis city circuit court in Missouri late on February 24. The law firms say the deal appears “unprecedented” and raises multiple “red flags”. Related: US chemical giant to stop producing herbicide called ‘toxic cocktail' by critics “It is hard to escape the impression that the proposed settlement would give Monsanto everything it desires – a near-complete release of liability for Monsanto and its parent company, Bayer AG – while giving inadequate consideration to many putative class mem
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone MetastasesBusiness Wire
- Bayer Aktiengesellschaft (BAYRY) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
- What to know about glyphosate, the herbicide behind a Trump executive order that's angered MAHA moms [CNN]CNN
- What to know about glyphosate, the herbicide behind a Trump executive order that's angered MAHA moms [CNN]CNN
- Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADABusiness Wire